HopeStage
Back to all studies
TerminatedNCT01019967

A Magnetic Resonance Spectroscopic Examination of Children and Adolescents Taking Riluzole for OCD

Observational studyAges 7–17United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 7 years to 17 years.

Listed locations
BethesdaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNovember 17, 2009
Recruitment status
Terminated
Enrollment listed in the registry
17
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
United States
Age range
From 7 Years to 17 Years
Official registry ID
NCT01019967
Official title
Show the full official title

A Magnetic Resonance Spectroscopic Examination of Children and Adolescents Taking Riluzole for Obsessive-Compulsive Disorder

Recruitment & locations

Terminated

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Who can participate?

Listed age limits: 7 years to 17 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies